Quantitative structure-activity relationship studies on some novel anti-HIV thiourea derivatives with cytotoxicity data (CC50) in MT-4 cells

Letters in Drug Design and Discovery

Volumn 6, Issue 3, 2009, Pages 193-200

  Chen, Ke Xian ^a   Li, Zu Guang ^a   Xie, Hai Ying ^a   Gao, Jian Rong ^a  

^a ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Anti HIV activity; Genetic function approximation; Molecular field analysis; Quantitative structure activity relationship; Thiourea derivatives

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; THIOUREA DERIVATIVE;

ARTICLE; BIOLOGICAL ACTIVITY; CYTOTOXICITY; DRUG RECEPTOR BINDING; GENETIC FUNCTION APPROXIMATION; GENETIC PARTIAL LEAST SQUARE; HUMAN; HUMAN CELL; MOLECULAR FIELD ANALYSIS; PARTIAL LEAST SQUARES REGRESSION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL ANALYSIS; STEREOCHEMISTRY;

EID: 64949166613     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018009787847828     Document Type: Article

References (43)

1. Leonard, J.T.; Roy, K. Comparative QSAR modeling of CCR5 receptor binding affinity of substituted 1-(3,3-diphenylpropyl)- piperidinyl amides and ureas. Bioorg. Med. Chem. Lett., 2006, 16, 4467-74.
2. Leonard, J.T.; Roy, K. QSAR by LFER model of HIV protease inhibitor mannitol derivatives using FA-MLR, PCRA, and PLS techniques. Bioorg. Med. Chem., 2006, 14, 1039-46.
3. Hemmateenejad, B.; Tabaei, S.M.H.; Namvaran, F. Computeraided design of potential anti-HIV-1 non-nucleoside reverse transcriptase inhibitors by contraction of b-ring in TIBO derivatives. J. Mol. Struct. (Theochem.), 2005, 732, 39-45.
4. 50) of anti-HIV 5-pheny-l-phenylamino-1H- imidazole derivatives by artificial neural network trained with Levenberg-Marquardt algorithm. J. Mol. Graph. Model, 2007, 26, 360-67.
5. Leonard, J.T.; Roy, K. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors. Eur. J. Med. Chem., 2008, 43, 81-92.
6. Andersen, J.L.; Le Rouzic, E.; Planelles, V. HIV-1 Vpr: Mechanisms of G2 arrest and apoptosis. Exp. Mol. Pathol, 2008, 85, 2-10.
7. De Clercq, E. New developments in anti-HIV chemotherapy. II Farmaco, 2001, 56, 3-12.
8. Jochmans, D. Novel HIV-1 reverse transcriptase inhibitors. Virus Res., 2008, 134, 171-85.
9. Dubey, S.; Satyanarayana, Y.D.; Lavania, H. Development of integrase inhibitors for treatment of AIDS: An overview. Eur. J. Med. Chem., 2007, 42, 1159-68.
10. Chen, K.-X.; Xie, H.-Y.; Li, Z.-G.; Gao, J.-R. Quantitative structure-activity relationship studies on 1-aryl-tetrahydroisoquinoline analogs as active anti-HIV agents. Bioorg. Med. Chem.Lett., 2008, 18, 5381-86.
11. Li, Z.-G.; Chen, K.-X.; Xie, H.-Y.; Gao, J.-R. Quantitative structure-activity relationship analysis of some thiourea derivatives with activities against HIV-1 (IIIB). QSAR Comb. Sci., 2009, 28, 87-97.
12. Martinez-Picado, J.; Martínez, M.A. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: A view from the clinic and ex vivo. Virus Res., 2008, 134, 104-23.
13. Küçükgüzel, Í; Tatar, E.; Küçükgüzel, Ş.G.; Rollas, S.; De Clercq, E. Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy) methyl]-4-alkyl/aryl-2,4- dihydro-3H-1,2,4- triazole-3-thiones and evaluation as antiviral/anti-HIV and anti- tuberculosis agents. Eur. J. Med. Chem., 2008, 43, 381-92.
14. Abrescia, N.; D'Abbraccio, M.; Busto, A.; Maddaloni, A.; Figoni, M.; De Marco, M. Antiretroviral therapy: Is it the right time for new strategies? Lett. Drug Des. Discov., 2005, 2, 470-74.
15. Tsutsumi, H.; Tamamura, H.; Fujii, N. Inhibitors of the chemokine receptor CXCR4: Chemotherapy of AIDS, metastatic cancer, leukemia and rheumatoid arthritis. Lett. Drug Des. Discov., 2007, 4, 20-26.
16. Yuan, H.; Parrill, A. Cluster analysis and three-dimensional QSAR studies of HIV-1 integrase inhibitors. J. Mol. Graph. Model., 2005, 23, 317-28.
17. Liu, S.; Jiang, S.; Wu, Z.; Lv, L.; Zhang, J.; Zhu, Z.; Wu, S. Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte. Life Sci., 2002, 71, 1779-91.
18. Hansch, C.; Kurup, A.; Garg, R.; Gao, H. Chem-Bioinformatics and QSAR. A review of QSAR lacking positive hydrophobic terms. Chem. Rev., 2001, 101, 619-72.
19. Hansch, C.; Maloney, P.P.; Fujita, T.; Muir, R.M. Correlation of biological activity of phenoxyacetic acids with hammett substituent constants and partition coefficients. Nature, 1962, 194, 178-80.
20. Yuan, H.; Parrill, A.L. QSAR development to describe HIV-1 integrase inhibition. J. Mol. Struct. (Theochem), 2000, 529, 273-82.
21. Hou, T.; Xu, X. A new molecular simulation software package- Peking University Drug Design System (PKUDDS) for structurebased drug design. J. Mol. Graph. Model., 2001, 19, 455-65.
22. Yang, G.; Huang, X. Development of quantitative structure-activity relationships and its application in rational drug design. Curr. Pharm. Des., 2006, 12, 4601-11.
23. Lill, M.A. Multi-dimensional QSAR in drug discovery. Drug Discov. Today, 2007, 12, 1013-17.
24. Hansch, C.; Leo, A. Exploring QSAR fundamentals and applications in chemistry and biology, ACS Professional Reference Book, American Chemical Society, Washington DC, 1995.
25. Juan, A.A.S. Structural investigation of PAP derivatives by CoMFA and CoMSIA reveals novel insight towards inhibition of Bcr-Abl oncoprotein. J. Mol. Graph. Model., 2007, 26, 482-93.
26. 2, version 4.10, 2005, A. San Diego, Inc.CA, USA.
27. Nair, P.C.; Sobhia, M.E. Quantitative structure-activity relationship studies on thiourea analogues as influenza virus neuraminidase inhibitors. Eur. J.Med. Chem., 2008, 43, 293-99.
28. Rappe, A.K.; Casewit, C.J.; Colwell, K.S.; Goddard, W.A.; Skiff, W.M. UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations. J. Am. Chem. Soc., 1992, 114, 10024-35.
29. Gasteiger, J.; Marsili, M. Iterative partial equalization of orbital electronegativity-a rapid access to atomic charges. Tetrahedron, 1980, 36, 3291-28.
30. Taha, M.O.; Bustanji, Y.; Al-Bakri, A.G.; Yousef, A.-M.; Zalloum, W.A.; Al-Masri, I.M.; Atallah, N. Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening. J. Mol. Graph. Model., 2007, 25, 870-84.
31. Rogers, D.; Hopfinger, A.J. Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships. J. Chem. Inf. Comput. Sci., 1994, 34, 854-66.
32. Friedman, J.H. Multivariate adaptive regression splines (with discussion). Ann. Statistics, 1991, 19, 1-141.
33. Holland, J. Adaptation in Artificial and Natural System, University of Michigan Press: Ann Arbor, 1975.
34. 2.GA. QSAR Comb. Sci., 2007, 26, 608-17.
35. Hirashima, A.; Eiraku, T.; Kuwano, E.; Eto, M. Three-dimensional molecular field analyses of agonists for tyramine receptor which inhibit sex-pheromone production in Plodia interpunctella. Internet Electron. J. Mol. Des., 2003, 2, 511-26.
36. A α3 receptor, and pharmacophore-based virtual screening approach. J. Mol. Graph. Model, 2008, 27, 286-98.
37. Equbal, T.; Silakari, O.; Ravikumar, M. Exploring threedimensional quantitative structural activity relationship (3D- QSAR) analysis of SCH 66336 (Sarasar) analogues of farnesyltransferase inhibitors. Eur. J. Med. Chem., 2008, 43, 204-09.
38. Deswal, S.; Roy, N. Quantitative structure activity relationship studies of aryl heterocycle-based thrombin inhibitors. Eur. J. Med. Chem., 2006, 41, 1339-46.
39. Fan, Y.; Shi, L.M.; Kohn, K.W.; Pommier, Y.; Weinstein, J.N. Quantitative structure-antitumor activity relationships of camptothecin analogues: cluster analysis and genetic algorithm-based studies. J. Med. Chem., 2001, 44, 3254-63.
40. Hall, L.H.; Kier, L.B. Electrotopological state indices for atom types: a novel combination of electronic, topological and valence state information. J. Chem. Inf. Comput. Sci., 1995, 35, 1039-45.
41. Hirashima, A.; Morimoto, M.; Kuwanoa, E.; Eto, M. Threedimensional molecular-field analyses of octopaminergic agonists for the cockroach neuronal octopamine receptor. Bioorg. Med. Chem., 2003, 11, 3753-60.
42. Raichurkar, A.V.; Kulkarni, V.M. 3D-QSAR of cyclooxygenase-2 inhibitors by genetic function approximation. Internet Electron. J. Mol. Des., 2003, 2, 242-61.
43. Golbraikh, A.; Tropsha, A. Beware of q2! J. Mol. Graph. Model., 2002, 20, 269-76.